The Aftermath ... | IDRA Message Board Posts


Idera Pharmaceuticals, Inc

  IDRA website

IDRA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1730 of 1739  at  3/19/2021 11:59:34 AM  by

auh2oman


The Aftermath ...

No doubt this was a major setback for Idera & the tilsotolimod program, but to quote the legendary Yogi Berra, " it ain't over til it's over!" Having experienced similar events(setbacks) with previously owned biotechs, I know first hand the gut retching feeling felt yesterday afternoon by too many of us! But, there are other trials, Illuminate-206& the  intradermal trial in the Netherlands, which could provide  substantial new info that might very well validate tilso in other indications. There is still more data from illuminate-301 forthcoming. Have no idea about OS, but that still is the gold standard for cancer related trials. Dr.ElizabethTarka, MD, Chief Medical Officer, stated in a conference call over a year and half ago that the disease control rate correlates very closely with overall survival. What that number will be is anyone's guess, but until then it's still in play. This long term stockholder will remain in a wait and see mode until further notice.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
1734 Re: The Aftermath ... raferjack 0 3/19/2021 5:42:21 PM


Financial Market Data provided by
.
Loading...